Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450749 · ClinicalTrials.gov registry record · Phase 2
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00450749: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00450749 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00450749, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.
Interventions
- OTHER laboratory biomarker analysis
- OTHER placebo
- PROCEDURE therapeutic conventional surgery
- DRUG lycopene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00450749
The ClinicalTrials.gov registry entry for NCT00450749 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.
NCT00450749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00450749 about?
NCT00450749 is a clinical study titled "Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer". This randomized phase II trial studies how well different doses of lycopene work in treating patients undergoing radical prostatectomy for prostate cancer. The use of lycopene, a substance found in tomatoes, may keep prostate cancer from growing or coming back after surgery.
What is the current status of trial NCT00450749?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2008-02. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00450749?
The interventions under investigation include: laboratory biomarker analysis (OTHER), placebo (OTHER), therapeutic conventional surgery (PROCEDURE), lycopene (DRUG).
Who is sponsoring clinical trial NCT00450749?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.